Show simple item record

dc.contributor.authorForde, Jonathan E.en
dc.contributor.authorCiupe, Mihaela Stancaen
dc.contributor.authorCintron-Arias, Arielen
dc.contributor.authorLenhart, Suzanneen
dc.identifier.citationForde, J.E.; Ciupe, S.M.; Cintron-Arias, A.; Lenhart, S. Optimal Control of Drug Therapy in a Hepatitis B Model. Appl. Sci. 2016, 6, 219.en
dc.description.abstractCombination antiviral drug therapy improves the survival rates of patients chronically infected with hepatitis B virus by controlling viral replication and enhancing immune responses. Some of these drugs have side effects that make them unsuitable for long-term administration. To address the trade-off between the positive and negative effects of the combination therapy, we investigated an optimal control problem for a delay differential equation model of immune responses to hepatitis virus B infection. Our optimal control problem investigates the interplay between virological and immunomodulatory effects of therapy, the control of viremia and the administration of the minimal dosage over a short period of time. Our numerical results show that the high drug levels that induce immune modulation rather than suppression of virological factors are essential for the clearance of hepatitis B virus.en
dc.rightsCreative Commons Attribution 4.0 Internationalen
dc.titleOptimal Control of Drug Therapy in a Hepatitis B Modelen
dc.typeArticle - Refereeden
dc.title.serialApplied Sciencesen

Files in this item


This item appears in the following Collection(s)

Show simple item record

Creative Commons Attribution 4.0 International
License: Creative Commons Attribution 4.0 International